Phase 2CompletedINTERVENTIONAL
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
ClinicalTrials.gov · NCT03696121 · Registry updated: 2022-11-15
- Condition / research focus
- Stroke, Acute
- Sponsor
- University of Nottingham
- Countries with listed sites
- United Kingdom
- Registry dates and results
- Start: 2019-04-01. Completion: 2022-06-30 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Desmopressin Injection (drug)
- Normal saline (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Nottingham City Hospital
Nottingham, Notts, United Kingdom
Site recruitment: Not reported